Literature DB >> 23353868

Stem cell therapies for liver failure and cirrhosis.

Zheng Zhang1, Fu-Sheng Wang.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23353868     DOI： 10.1016/j.jhep.2013.01.018

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  44 in total

1.  A small molecule Hedgehog agonist HhAg1.5 mediated reprogramming breaks the quiescence of noninjured liver stem cells for rescuing liver failure.

Authors:  Abhisek Mitra; Jun Yan; Liangfang Zhang; Shulin Li
Journal:  Transl Res       Date:  2018-10-19       Impact factor: 7.012

2.  Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway.

Authors:  Ji Xuan; Wang Feng; Zheng-Tao An; Jian Yang; Hua-Bing Xu; Jing Li; Zhi-Fei Zhao; Wei Wen
Journal:  Mol Cell Biochem       Date:  2017-02-08       Impact factor: 3.396

3.  Mesenchymal Stem Cell/Red Blood Cell-Inspired Nanoparticle Therapy in Mice with Carbon Tetrachloride-Induced Acute Liver Failure.

Authors:  Hongxia Liang; Ke Huang; Teng Su; Zhenhua Li; Shiqi Hu; Phuong-Uyen Dinh; Emily A Wrona; Chen Shao; Li Qiao; Adam C Vandergriff; M Taylor Hensley; Jhon Cores; Tyler Allen; Hongyu Zhang; Qinglei Zeng; Jiyuan Xing; Donald O Freytes; Deliang Shen; Zujiang Yu; Ke Cheng
Journal:  ACS Nano       Date:  2018-06-26       Impact factor: 15.881

Review 4.  Acute-on-chronic Liver Failure.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Curr Gastroenterol Rep       Date:  2016-12

Review 5.  Stem cell transplantation for treating liver diseases: progress and remaining challenges.

Authors:  Shanshan Li; Yanzhen Bi; Zhongping Duan; Yongkai Chang; Feng Hong; Yu Chen
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

6.  Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl₄-treated rats.

Authors:  Yingwei Zhu; Zongning Miao; Lei Gong; Weichang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

7.  Precise Regulation of miR-210 Is Critical for the Cellular Homeostasis Maintenance and Transplantation Efficacy Enhancement of Mesenchymal Stem Cells in Acute Liver Failure Therapy.

Authors:  Yingxia Liu; Yongjia Xiong; Feiyue Xing; Hao Gao; Xiaogang Wang; Liumin He; Chaoran Ren; Lei Liu; Kwok-Fai So; Jia Xiao
Journal:  Cell Transplant       Date:  2016-12-13       Impact factor: 4.064

Review 8.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 9.  Management of acute-on-chronic liver failure: an algorithmic approach.

Authors:  Shiv Kumar Sarin; Ashok Choudhury
Journal:  Hepatol Int       Date:  2018-08-16       Impact factor: 6.047

Review 10.  Concise review: clinical programs of stem cell therapies for liver and pancreas.

Authors:  Giacomo Lanzoni; Tsunekazu Oikawa; Yunfang Wang; Cai-Bin Cui; Guido Carpino; Vincenzo Cardinale; David Gerber; Mara Gabriel; Juan Dominguez-Bendala; Mark E Furth; Eugenio Gaudio; Domenico Alvaro; Luca Inverardi; Lola M Reid
Journal:  Stem Cells       Date:  2013-10       Impact factor: 6.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.